The qRT-PCR results of the clinical cohort revealed that IGFBP2 was elevated in RA SFs compared with the healthy controls (HCs) (P = 0.008), and METTL3 was downregulated in RA SFs compared with HCs (P = 0.027) (Figure 7). This evidence concerns the gene METTL3 and rheumatoid arthritis.